Press Releases
-
Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research
-
Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection
-
CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery
-
Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening
-
DDA Platform Offers A Wide Range of in Vitro and in Vivo Assays to Cover Early Stage Drug Discovery
-
Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models
-
Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation
-
Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant
-
Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service
-
Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals
-
Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins
-
Elligo’s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council
Elligo Health Research® today announced Chief Scientific Officer Rebecca Kush, Ph.D., will bring her expertise in clinical research, standards, and interoperability to her role as recently elected Chair of the Vulcan Advisory Council.
Sep 20, 2022
-
WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research
WCG today announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators.
Sep 12, 2022
-
Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit
Dr. Vince Clinical Research (DVCR) today announced the launch of its new, world-class clinical pharmacology unit and headquarters in Overland Park, Kansas.
Sep 19, 2022
-
University of Maryland School of Pharmacy Taps Komodo Health Platform To Power Real-World Evidence Research
Studies Will Examine Social Determinants of Health, Impact of Policy on Access, and Pandemic-Driven Disruptions to Healthcare Delivery
Sep 20, 2022
-
Quinten Health closes its financing round to advance disease modeling platforms and virtual twins in real-world
QUINTEN HEALTH has announced that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world.
Sep 20, 2022
-
Dolomite Bio launches Nadia Go - An affordable microfluidic system for custom protocol development
Dolomite Bio has announced the launch of Nadia Go — an affordable microfluidic system for custom microfluidic and genomics research.
Sep 20, 2022
-
Tower to bring the temperature of pharmaceutical logistics to CPhI
Temperature-controlled containers that combine robust, reliable, and reusable benefits for the pharmaceutical supply chain will be showcased on the Tower Cold Chain stand, 91H66, zone ICSE, at this year’s CPhI worldwide, in Frankfurt.
Sep 20, 2022
-
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
-
Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology